851086-84-5Relevant academic research and scientific papers
STIGMINE CONJUGATES FOR SUBSTANCE USE DISORDERS
-
Page/Page column 27-28, (2010/04/03)
The invention relates to methods for the treatment or prevention of substance use disorders.
Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
-
Page/Page column 18-19, (2008/06/13)
Carbamoyl esters inhibit cholinesterase activity and, upon hydrolysis release a pharmacologically active agent. In one embodiment, the carbamoyl ester has the following structure: wherein A is selected from the group consisting of an unsubstituted aryl, a substituted aryl, an unsubstituted heteroaryl and a substituted heteroaryl. The carbamoyl esters are employed in methods to treat an individual. The pharmacologically active agent obtained by hydrolysis of the carbamoyl esters can treat, for example, a nervous system condition, a cholinergic deficiency and conditions or diseases associated with a deficiency in a pharmacologically active agent, such as acetylcholine.
